Literature DB >> 31155233

Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer.

Matteo Ligorio1, Srinjoy Sil2, Jose Malagon-Lopez3, Linda T Nieman2, Sandra Misale2, Mauro Di Pilato4, Richard Y Ebright2, Murat N Karabacak5, Anupriya S Kulkarni2, Ann Liu2, Nicole Vincent Jordan2, Joseph W Franses2, Julia Philipp2, Johannes Kreuzer2, Niyati Desai2, Kshitij S Arora6, Mihir Rajurkar2, Elad Horwitz2, Azfar Neyaz2, Eric Tai2, Neelima K C Magnus2, Kevin D Vo2, Chittampalli N Yashaswini2, Francesco Marangoni4, Myriam Boukhali2, Jackson P Fatherree2, Leah J Damon2, Kristina Xega2, Rushil Desai2, Melissa Choz2, Francesca Bersani2, Adam Langenbucher2, Vishal Thapar3, Robert Morris2, Ulrich F Wellner7, Oliver Schilling8, Michael S Lawrence2, Andrew S Liss9, Miguel N Rivera3, Vikram Deshpande3, Cyril H Benes2, Shyamala Maheswaran1, Daniel A Haber10, Carlos Fernandez-Del-Castillo1, Cristina R Ferrone1, Wilhelm Haas2, Martin J Aryee11, David T Ting12.   

Abstract

Single-cell technologies have described heterogeneity across tissues, but the spatial distribution and forces that drive single-cell phenotypes have not been well defined. Combining single-cell RNA and protein analytics in studying the role of stromal cancer-associated fibroblasts (CAFs) in modulating heterogeneity in pancreatic cancer (pancreatic ductal adenocarcinoma [PDAC]) model systems, we have identified significant single-cell population shifts toward invasive epithelial-to-mesenchymal transition (EMT) and proliferative (PRO) phenotypes linked with mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) signaling. Using high-content digital imaging of RNA in situ hybridization in 195 PDAC tumors, we quantified these EMT and PRO subpopulations in 319,626 individual cancer cells that can be classified within the context of distinct tumor gland "units." Tumor gland typing provided an additional layer of intratumoral heterogeneity that was associated with differences in stromal abundance and clinical outcomes. This demonstrates the impact of the stroma in shaping tumor architecture by altering inherent patterns of tumor glands in human PDAC.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  mass spectrometry; pancreatic cancer; pancreatic ductal adenocarcinoma; single cell RNA-sequencing; single cell spatial analysis; stromal microenvironment; tumor architecture

Mesh:

Substances:

Year:  2019        PMID: 31155233      PMCID: PMC6697165          DOI: 10.1016/j.cell.2019.05.012

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  A tissue-specific atlas of mouse protein phosphorylation and expression.

Authors:  Edward L Huttlin; Mark P Jedrychowski; Joshua E Elias; Tapasree Goswami; Ramin Rad; Sean A Beausoleil; Judit Villén; Wilhelm Haas; Mathew E Sowa; Steven P Gygi
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

2.  A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

Authors:  Sean A Beausoleil; Judit Villén; Scott A Gerber; John Rush; Steven P Gygi
Journal:  Nat Biotechnol       Date:  2006-09-10       Impact factor: 54.908

3.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.

Authors:  Joshua E Elias; Steven P Gygi
Journal:  Nat Methods       Date:  2007-03       Impact factor: 28.547

4.  Role of pancreatic stellate cells in pancreatic cancer metastasis.

Authors:  Zhihong Xu; Alain Vonlaufen; Phoebe A Phillips; Eva Fiala-Beer; Xuguo Zhang; Lu Yang; Andrew V Biankin; David Goldstein; Romano C Pirola; Jeremy S Wilson; Minoti V Apte
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

5.  Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells.

Authors:  Shin Hamada; Atsushi Masamune; Tetsuya Takikawa; Noriaki Suzuki; Kazuhiro Kikuta; Morihisa Hirota; Hirofumi Hamada; Masayoshi Kobune; Kennichi Satoh; Tooru Shimosegawa
Journal:  Biochem Biophys Res Commun       Date:  2012-04-09       Impact factor: 3.575

6.  Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.

Authors:  Jeffrey R Infante; Hiroyuki Matsubayashi; Norihiro Sato; James Tonascia; Alison P Klein; Taylor A Riall; Charles Yeo; Christine Iacobuzio-Donahue; Michael Goggins
Journal:  J Clin Oncol       Date:  2007-01-20       Impact factor: 44.544

7.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion.

Authors:  Carolyn E Clark; Sunil R Hingorani; Rosemarie Mick; Chelsea Combs; David A Tuveson; Robert H Vonderheide
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

8.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

Authors:  Kenneth P Olive; Michael A Jacobetz; Christian J Davidson; Aarthi Gopinathan; Dominick McIntyre; Davina Honess; Basetti Madhu; Mae A Goldgraben; Meredith E Caldwell; David Allard; Kristopher K Frese; Gina Denicola; Christine Feig; Chelsea Combs; Stephen P Winter; Heather Ireland-Zecchini; Stefanie Reichelt; William J Howat; Alex Chang; Mousumi Dhara; Lifu Wang; Felix Rückert; Robert Grützmann; Christian Pilarsky; Kamel Izeradjene; Sunil R Hingorani; Pearl Huang; Susan E Davies; William Plunkett; Merrill Egorin; Ralph H Hruban; Nigel Whitebread; Karen McGovern; Julian Adams; Christine Iacobuzio-Donahue; John Griffiths; David A Tuveson
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics.

Authors:  Lily Ting; Ramin Rad; Steven P Gygi; Wilhelm Haas
Journal:  Nat Methods       Date:  2011-10-02       Impact factor: 28.547

View more
  147 in total

Review 1.  Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.

Authors:  Xi Hu; Fan Xia; Jiyoung Lee; Fangyuan Li; Xiaoyang Lu; Xiaozhen Zhuo; Guangjun Nie; Daishun Ling
Journal:  Adv Sci (Weinh)       Date:  2021-02-12       Impact factor: 16.806

Review 2.  Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.

Authors:  Eric S Christenson; Elizabeth Jaffee; Nilofer S Azad
Journal:  Lancet Oncol       Date:  2020-03       Impact factor: 41.316

3.  Cancer associated fibroblast: Mediators of tumorigenesis.

Authors:  Jennifer Alexander; Edna Cukierman
Journal:  Matrix Biol       Date:  2020-05-22       Impact factor: 11.583

4.  Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas.

Authors:  Reuben Moncada; Dalia Barkley; Florian Wagner; Marta Chiodin; Joseph C Devlin; Maayan Baron; Cristina H Hajdu; Diane M Simeone; Itai Yanai
Journal:  Nat Biotechnol       Date:  2020-01-13       Impact factor: 54.908

5.  Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit.

Authors:  Bailiang Li; Yuming Jiang; Guoxin Li; George A Fisher; Ruijiang Li
Journal:  JCI Insight       Date:  2020-05-07

6.  Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer.

Authors:  Linara Gabitova-Cornell; Aizhan Surumbayeva; Suraj Peri; Janusz Franco-Barraza; Diana Restifo; Nicole Weitz; Charline Ogier; Aaron R Goldman; Tiffiney R Hartman; Ralph Francescone; Yinfei Tan; Emmanuelle Nicolas; Neelima Shah; Elizabeth A Handorf; Kathy Q Cai; Alana M O'Reilly; Ido Sloma; Rachel Chiaverelli; Richard A Moffitt; Vladimir Khazak; Carolyn Y Fang; Erica A Golemis; Edna Cukierman; Igor Astsaturov
Journal:  Cancer Cell       Date:  2020-09-24       Impact factor: 31.743

Review 7.  The Frequency of Ras Mutations in Cancer.

Authors:  Ian A Prior; Fiona E Hood; James L Hartley
Journal:  Cancer Res       Date:  2020-03-24       Impact factor: 12.701

8.  Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.

Authors:  Hongyang Yi; Guipeng Li; Yongkang Long; Weizheng Liang; Huanhuan Cui; Bin Zhang; Ying Tan; Yunfei Li; Luochen Shen; Daqi Deng; Yisen Tang; Chenyu Mao; Shuye Tian; Yunting Cai; Qionghua Zhu; Yuhui Hu; Wei Chen; Liang Fang
Journal:  Oncogene       Date:  2020-06-13       Impact factor: 9.867

Review 9.  Use of Single-Cell -Omic Technologies to Study the Gastrointestinal Tract and Diseases, From Single Cell Identities to Patient Features.

Authors:  Mirazul Islam; Bob Chen; Jeffrey M Spraggins; Ryan T Kelly; Ken S Lau
Journal:  Gastroenterology       Date:  2020-05-14       Impact factor: 22.682

Review 10.  Evolving Treatment Paradigms for Pancreatic Cancer.

Authors:  Rami Abbassi; Roland M Schmid
Journal:  Visc Med       Date:  2019-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.